Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-09-21 00:00:00 ET · period of report 2022-09-19 · accession 0001562180-22-006788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-21 | 2022-09-19+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $23.11 | -174.0K | 17.8K | -91% | -$4.02M |
| DM | 2022-09-21 | 2022-09-19+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $10.90 | +174.0K | 132.2K | New | +$1.90M |
| DM | 2022-09-21 | 2022-09-19+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $0.00 | -174.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-19 | S | D | 114,339 | $23.03 | 17,836 | D | — | — | (F2) The sale prices ranged from $22.50 to $23.35 |
| 2 | Common | Common Stock | 2022-09-20 | M | A | 59,649 | $10.90 | 77,485 | D | — | — | |
| 3 | Common | Common Stock | 2022-09-20 | S | D | 59,649 | $23.25 | 17,836 | D | — | — | (F3) The sale prices ranged from $22.60 to $23.75 |
| 4 | Common | Common Stock | 2022-09-19 | M | A | 114,339 | $10.90 | 132,175 | D | — | — | |
| 5 | Derivative | Stock Options (Right to buy) | 2022-09-20 | M | D | 59,649 | $0.00 | 0 | D | $10.90 · — to 2025-09-09 | 59,649 Common Stock | (F4) This option is fully vested. |
| 6 | Derivative | Stock Options (Right to buy) | 2022-09-19 | M | D | 114,339 | $0.00 | 0 | D | $10.90 · — to 2025-09-09 | 114,339 Common Stock | (F4) This option is fully vested. |